China Cell And Gene Therapy CDMO Market (2025-2031) | Companies, Outlook, Competitive Landscape, Analysis, Growth, Segmentation, Trends, Forecast, Industry, Value, Share, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 China Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 China Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 China Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 China Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 China Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders in China

4.2.2 Growing investment in cell and gene therapy research and development

4.2.3 Favorable government initiatives and policies supporting cell and gene therapy industry growth in China

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for cell and gene therapy products in China

4.3.2 Limited manufacturing capacity and expertise in cell and gene therapy CDMO sector in China

6.1 China Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 China Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 China Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 China Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 China Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 China Cell And Gene Therapy CDMO Market Imports from Major Countries

8.1 Number of clinical trials for cell and gene therapy in China

8.2 Investment in cell and gene therapy startups and companies in China

8.3 Number of partnerships and collaborations between international and domestic players in the cell and gene therapy industry in China

9.1 China Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 China Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 China Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 China Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 China Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters